The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Open accessAbstract
In acute myeloid leukaemia (AML), the cell of origin, nature and biological consequences of initiating lesions, and order of subsequent mutations remain poorly understood, as AML is typically diagnosed without observation of a pre-leukaemic phase. Here, highly purified haematopoietic stem cells (HSCs), progenitor and mature cell fractions from the blood of AML patients were found to contain recurrent DNMT3A mutations (DNMT3A(mut)) at high allele frequency, but without coincident NPM1 mutations (NPM1c) present in AML blasts. DNMT3A(mut)-bearing HSCs showed a multilineage repopulation advantage over non-mutated HSCs in xenografts, establishing their identity as pre-leukaemic HSCs. Pre-leukaemic HSCs were found in remission samples, indicating that they survive chemotherapy. Therefore DNMT3A(mut) arises early in AML evolution, probably in HSCs, leading to a clonally expanded pool of pre-leukaemic HSCs from which AML evolves. Our findings provide a paradigm for the detection and treatment of pre-leukaemic clones before the acquisition of additional genetic lesions engenders greater therapeutic resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies in patients with AML have confirmed the functional importance and clinical significance of preleukemic stem cell populations as the cellular origin of leukemia-initiating cells in human disease27, 48.”
From Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia (2015) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DNMT3A is also recurrently mutated in blood diseases such as acute myeloid leukemia (AML; ref. 9) and myelodysplastic syndromes (MDS; ref. 10) where it functions as an initiating mutation (11).”
From Txnip Enhances Fitness of Dnmt3a -Mutant Hematopoietic Stem Cells via p21 (2022) · cites this paper as [11]
Experimental — accuracy not yet measuredIn the citing paper
“In later studies, DNA sequencing of HSCs from AML patients in remission revealed that stem cells with only a single driver mutation were often present, suggesting that pre-malignant clonal hematopoiesis was a generalizable finding in AML 23–25.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,704
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Hu, Y., & Smyth, G. K. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.008 · Cited by 2,084
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012) · Nature · doi:10.1038/nature10738 · Cited by 1,993
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Patel, J. P., Gönen, M., Figueroa, M. E., Fernandez, H. F., Sun, Z., Racevskis, J., Vlierberghe, P. V., Dolgalev, I., Thomas, S., Aminova, O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112304 · Cited by 1,990
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Cited by
Sorted by citations
Items 301–400 of 1,000
Aging-elevated inflammation promotes DNMT3A R878H-driven clonal hematopoiesis
Liao, M., Chen, R., Yang, Y., He, H., Xu, L., Jiang, Y., Guo, Z., He, W., Jiang, H., & Wang, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.015 · Cited by 74
Self-citationEpigenetics in T‐cell acute lymphoblastic leukemia
Peirs, S., der Meulen, J. V., de Walle, I. V., Taghon, T., Speleman, F., Poppe, B. G., & Vlierberghe, P. V. (2014) · Immunological Reviews · doi:10.1111/imr.12237 · Cited by 76
Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity
Arnone, M., Konantz, M., Hanns, P., Stanger, A. M. P., Bertels, S., Godavarthy, P. S., Christopeit, M., & Lengerke, C. (2020) · Cancers · doi:10.3390/cancers12123742 · Cited by 70
Epigenetic regulation of hematopoietic stem cell aging
Beerman, I., & Rossi, D. J. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.013 · Cited by 77
The multifaceted functions of C/EBPα in normal and malignant haematopoiesis
Ohlsson, E., Schuster, M. B., Hasemann, M. S., & Porse, B. T. (2015) · Leukemia · doi:10.1038/leu.2015.324 · Cited by 84
The myeloma stem cell concept, revisited: from phenomenology to operational terms
Johnsen, H. E., Bøgsted, M., Schmitz, A., Bødker, J. S., El‐Galaly, T. C., Johansen, P., Valent, P., Zojer, N., Valckenborgh, E. V., Vanderkerken, K., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.138826 · Cited by 72
The role of targeted therapy in the management of patients with AML
Perl, A. E. (2017) · Hematology · doi:10.1182/asheducation-2017.1.54 · Cited by 71
Press, R. D., Eickelberg, G., Froman, A., Yang, F., Stentz, A., Flatley, E. M., Fan, G., Lim, J. Y., Meyers, G., Maziarz, R. T., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25514 · Cited by 70
CD 45 RA , a specific marker for leukaemia stem cell sub‐populations in acute myeloid leukaemia
Kersten, B., Valkering, M., Wouters, R., van Amerongen, R. A., Hanekamp, D., Kwidama, Z. J., Valk, P. J. M., Ossenkoppele, G. J., Zeijlemaker, W., Kaspers, G. J. L., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.13941 · Cited by 70
Yan, H., Wang, Z., Sun, Y., Hu, L., & Bu, P. (2021) · Advanced Science · doi:10.1002/advs.202100914 · Cited by 69
Cheng, Y., Gao, Z., Zhang, T., Wang, Y., Xie, X., Han, G., Li, Y., Yin, R., Chen, Y., Wang, P., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.12.003 · Cited by 71
Self-citationCakouros, D., & Gronthos, S. (2018) · Aging and Disease · doi:10.14336/ad.2017.1213 · Cited by 71
Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesis
Le, P. M., Andreeff, M., & Battula, V. L. (2018) · Haematologica · doi:10.3324/haematol.2018.197004 · Cited by 75
Clonal hematopoiesis and atherosclerosis
Oren, O., Small, A. M., & Libby, P. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180066 · Cited by 77
Control of cancer formation by intrinsic genetic noise and microenvironmental cues
Brock, A., Krause, S., & Ingber, D. E. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3959 · Cited by 72
Targeting novel signaling pathways for resistant acute myeloid leukemia
Sakamoto, K. M., Grant, S., Saleiro, D., Crispino, J. D., Hijiya, N., Giles, F. J., Platanias, L. C., & Eklund, E. A. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.11.017 · Cited by 69
Clonal Hematopoiesis and Blood-Cancer Risk
Genovese, G., Jaiswal, S., Ebert, B. L., & McCarroll, S. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1500684 · Cited by 70
Chaudry, S. F., & Chevassut, T. J. T. (2017) · BioMed Research International · doi:10.1155/2017/5473197 · Cited by 69
Handschuh, L. (2019) · Journal of Oncology · doi:10.1155/2019/7239206 · Cited by 66
Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
Zarka, J. G., Short, N. J., Kanagal‐Shamanna, R., & Issa, G. C. (2020) · Genes · doi:10.3390/genes11060649 · Cited by 68
Kirtonia, A., Pandya, G., Sethi, G., Pandey, A. K., Das, B. C., & Garg, M. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01944-5 · Cited by 68
Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis
Zioni, N., Bercovich, A. A., Chapal-Ilani, N., Bacharach, T., Rappoport, N., Solomon, A., Avraham, R., Kopitman, E., Porat, Z., Sacma, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36906-1 · Cited by 67
Self-citationPRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity
Zhou, B. O., Wang, J., Lee, S. Y., Xiong, J., Bhanu, N. V., Guo, Q., Ma, P., Sun, Y., Rao, R. C., Garcia, B. A., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.010 · Cited by 64
Self-citationfor the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG), Gaidzik, V. I., Weber, D., Paschka, P., Kaumanns, A., Krieger, S., Corbacioglu, A., Krönke, J., Kapp‐Schwoerer, S., Kraemer, D. M., et al. (2017) · Leukemia · doi:10.1038/leu.2017.200 · Cited by 69
Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias
Wang, K., Sánchez-Martín, M., Wang, X., Knapp, K. M., Koche, R. P., Vu, L., Nahas, M. K., He, J., Hadler, M., Stein, E. M., et al. (2016) · Leukemia · doi:10.1038/leu.2016.166 · Cited by 67
Rothe, K., Porter, V., & Jiang, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030461 · Cited by 67
Cortés-López, M., Chamely, P., Hawkins, A. G., Stanley, R. F., Swett, A. D., Ganesan, S., Mouhieddine, T. H., Dai, X., Kluegel, L., Chen, C. Y., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.07.012 · Cited by 69
Self-citationNovel insights into the pathogenesis of T-cell lymphomas
Arnam, J. S. V., Lim, M. S., & Elenitoba‐Johnson, K. S. J. (2018) · Blood · doi:10.1182/blood-2017-11-764357 · Cited by 68
The role of targeted therapy in the management of patients with AML
Perl, A. E. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017009829 · Cited by 68
Clonal hematopoiesis as a model for premalignant changes during aging
Steensma, D. P., & Ebert, B. L. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.001 · Cited by 65
Alterations to DNMT3A in Hematologic Malignancies
Venugopal, K., Feng, Y., Shabashvili, D. E., & Guryanova, O. A. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-3033 · Cited by 70
Adaptive response of resistant cancer cells to chemotherapy
Chern, Y., & Tai, I. T. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0005 · Cited by 67
Cancer stem cells: The adventurous journey from hematopoietic to leukemic stem cells
Trumpp, A., & Haas, S. F. (2022) · Cell · doi:10.1016/j.cell.2022.03.025 · Cited by 72
Brambati, C., Galbiati, S., Xue, E., Toffalori, C., Crucitti, L., Greco, R., Sala, E., Crippa, A., Chiesa, L., Soriani, N., et al. (2015) · Haematologica · doi:10.3324/haematol.2015.135467 · Cited by 67
Clinical implications of molecular markers in acute myeloid leukemia
Käyser, S., & Levis, M. J. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13172 · Cited by 70
Li, J., Lü, L., Zhang, Y., Xu, Y., Liu, M., Feng, K., Chen, L., Kong, X., Huang, T., & Cai, Y. (2019) · Cancer Gene Therapy · doi:10.1038/s41417-019-0105-y · Cited by 65
Midic, D., Rinke, J., Perner, F., Müller, V., Hinze, A., Pester, F., Landschulze, J., Ernst, J., Gruhn, B., Matziolis, G., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0869-y · Cited by 65
Single-cell genomics in AML: extending the frontiers of AML research
Ediriwickrema, A., Gentles, A. J., & Majeti, R. (2022) · Blood · doi:10.1182/blood.2021014670 · Cited by 69
The end of the genetic paradigm of cancer
Huang, S., Soto, A. M., & Sonnenschein, C. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003052 · Cited by 68
Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis
Natarajan, P., Jaiswal, S., & Kathiresan, S. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001926 · Cited by 63
Preleukemia: one name, many meanings
Koeffler, H. P., & Leong, G. X. Y. (2016) · Leukemia · doi:10.1038/leu.2016.364 · Cited by 67
The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML
Dunlap, J. B., Leonard, J. T., Rosenberg, M. W., Cook, R. J., Press, R. D., Fan, G., Raess, P. W., Druker, B. J., & Traer, E. A. (2019) · American Journal of Hematology · doi:10.1002/ajh.25517 · Cited by 64
Maintenance therapy for FLT3-ITD-mutated acute myeloid leukemia
Burchert, A. (2021) · Haematologica · doi:10.3324/haematol.2019.240747 · Cited by 65
A Zebrafish Model of Myelodysplastic Syndrome Produced through tet2 Genomic Editing
Gjini, E., Mansour, M. R., Sander, J. D., Moritz, N., Nguyen, A. T., Kesarsing, M., Gans, E., He, S., Chen, S., Ko, M., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00971-14 · Cited by 64
The crossroads between cancer stem cells and aging
Franco, S. S., Raveh-Amit, H., Kobolák, J., Al-Qahtani, M. H., Mobasheri, A., & Dinnyés, A. (2015) · BMC Cancer · doi:10.1186/1471-2407-15-s1-s1 · Cited by 63
Chen, Y., Li, J., Xu, L., Găman, M., & Zou, Z. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01193-0 · Cited by 69
Xiao, W., Bharadwaj, M. C., Levine, M. F., Farnoud, N. R., Pastore, F., Getta, B. M., Hultquist, A., Famulare, C. A., Medina-Martinez, J. S., Patel, M. A., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018023531 · Cited by 62
ASXL1 mutation in clonal hematopoiesis
Fujino, T., & Kitamura, T. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.002 · Cited by 64
CD200 expression marks leukemia stem cells in human AML
Ho, J., Dobson, S. M., Voisin, V., McLeod, J. L., Kennedy, J. A., Mitchell, A., Jin, L., Eppert, K., Bader, G. D., Minden, M. D., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001802 · Cited by 62
Self-citationJahn, E., Saadati, M., Fenaux, P., Gobbi, M., Roboz, G. J., Bullinger, L., Lutsik, P., Riedel, A., Plass, C., Jahn, N., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01999-6 · Cited by 62
T memory stem cells are the hierarchical apex of adult T-cell leukemia
Nagai, Y., Kawahara, M., Hishizawa, M., Shimazu, Y., Sugino, N., Fujii, S., Kadowaki, N., & Takaori‐Kondo, A. (2015) · Blood · doi:10.1182/blood-2014-10-607465 · Cited by 61
Ogawara, Y., Katsumoto, T., Aikawa, Y., Shima, Y., Kagiyama, Y., Soga, T., Matsunaga, H., Seki, T., Araki, K., & Kitabayashi, I. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2200 · Cited by 58
Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA
Konstandin, N. P., Pastore, F., Herold, T., Dufour, A. M., Rothenberg‐Thurley, M., Hinrichsen, T., Ksienzyk, B., Tschuri, S., Schneider, S., Hoster, E., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018016840 · Cited by 61
Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia
Lundgren, S., Keränen, M. A. I., Kankainen, M., Huuhtanen, J., Walldin, G., Kerr, C. M., Clemente, M. J., Ebeling, F. T., Rajala, H. L. M., Brück, O. E., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01231-3 · Cited by 63
Miari, K. E., Guzmán, M. L., Wheadon, H., & Williams, M. T. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.692800 · Cited by 62
Erdem, A., Marín, S., Pereira‐Martins, D. A., Cortés, R., Cunningham, A., Pruis, M. G. M., de Boer, B., van den Heuvel, F. A. J., Geugien, M., Wierenga, A. T. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28737-3 · Cited by 59
The role of mutations in epigenetic regulators in myeloid malignancies
Woods, B. A., & Levine, R. L. (2014) · Immunological Reviews · doi:10.1111/imr.12246 · Cited by 63
Dysregulation of TET2 in hematologic malignancies
Chiba, S. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2122-z · Cited by 62
Bond, J., Touzart, A., Leprêtre, S., Graux, C., Bargetzi, M. J., Lhermitte, L., Hypolite, G., Leguay, T., Hicheri, Y., Guillerm, G., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.197848 · Cited by 64
Acute Myeloid Leukemia: Aging and Epigenetics
Zjablovskaja, P., & Florian, M. C. (2019) · Cancers · doi:10.3390/cancers12010103 · Cited by 61
Grants, J. M., Węgrzyn, J., Hui, T., O’Neill, K., Shadbolt, M., Knapp, D. J. H. F., Parker, J., Deng, Y., Gopal, A., Docking, R., et al. (2020) · Blood · doi:10.1182/blood.2019003105 · Cited by 62
Clonal reversal of ageing-associated stem cell lineage bias via a pluripotent intermediate
Wahlestedt, M., Erlandsson, E., Kristiansen, T., Lu, R., Brakebusch, C., Weissman, I. L., Yuan, J., Martin-Gonzalez, J., & Bryder, D. (2017) · Nature Communications · doi:10.1038/ncomms14533 · Cited by 59
Sun, Y., Chen, B.-R., & Deshpande, A. J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00041 · Cited by 64
Reconciling Non-Genetic Plasticity with Somatic Evolution in Cancer
Huang, S. (2021) · Trends in cancer · doi:10.1016/j.trecan.2020.12.007 · Cited by 60
Ahn, J., Kim, H., Kim, Y.-K., Lee, S.-S., Jung, S.-H., Yang, D.-H., Lee, J.-J., Kim, N. Y., Choi, S. H., Jung, C. W., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.07.030 · Cited by 61
Self-citationRole of protein phosphatases in the cancer microenvironment
Ruvolo, P. P. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.07.006 · Cited by 64
Cord Blood Banking for Potential Future Transplantation
Shearer, W. T., Lubin, B. H., Cairo, M. S., Notarangelo, L. D., HEMATOLOGY/ONCOLOGY, S. O., IMMUNOLOGY, S. O. A. A., Hord, J., Crouch, G., Hale, G. A., Harper, J., et al. (2017) · PEDIATRICS · doi:10.1542/peds.2017-2695 · Cited by 59
Self-citationClonal Hematopoiesis: From Mechanisms to Clinical Intervention
Köhnke, T., & Majeti, R. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0901 · Cited by 63
Leukemia-associated activating mutation of Flt3 expands dendritic cells and alters T cell responses
Lau, C. M., Nish, S. A., Yogev, N., Waisman, A., Reiner, S. L., & Reizis, B. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20150642 · Cited by 58
Amon, S., Meier‐Abt, F., Gillet, L. C. J., Dimitrieva, S., Theocharides, A. P. A., Manz, M. G., & Aebersold, R. H. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir119.001431 · Cited by 60
Duncavage, E. J., & Tandon, B. (2015) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12361 · Cited by 58
Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia
Stuani, L., Sabatier, M., & Sarry, J. (2019) · BMC Biology · doi:10.1186/s12915-019-0670-4 · Cited by 66
Hand in hand: intrinsic and extrinsic drivers of aging and clonal hematopoiesis
SanMiguel, J. M., Young, K. A., & Trowbridge, J. J. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.09.197 · Cited by 59
Hoang, V. T., Buss, E. C., Wang, W., Hoffmann, I., Raffel, S., Zepeda‐Moreno, A., Baran, N., Wuchter, P., Eckstein, V., Trumpp, A., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29410 · Cited by 57
Wada, T., Koyama, D., Kikuchi, J., Honda, H., & Furukawa, Y. (2015) · Blood · doi:10.1182/blood-2014-11-610907 · Cited by 57
Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy
Gill, H., Leung, A. Y. H., & Kwong, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040440 · Cited by 58
Accumulation of DNA damage in the aged hematopoietic stem cell compartment
Beerman, I. (2016) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.11.001 · Cited by 55
Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors
Booth, C. A. G., Barkas, N., Neo, W. H., Boukarabila, H., Soilleux, E. J., Giotopoulos, G., Farnoud, N., Giustacchini, A., Ashley, N., Carrelha, J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.006 · Cited by 57
Yasuda, T., Sanada, M., Kawazu, M., Kojima, S., Tsuzuki, S., Ueno, H., Iwamoto, E., Iijima‐Yamashita, Y., Yamada, T., Kanamori, T., et al. (2021) · Blood · doi:10.1182/blood.2021011921 · Cited by 60
‘CHIP’ping away at clonal hematopoiesis
Link, D. C., & Walter, M. J. (2016) · Leukemia · doi:10.1038/leu.2016.130 · Cited by 57
Balancing DNA repair to prevent ageing and cancer
Stead, E. R., & Bjedov, I. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112679 · Cited by 62
Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis
Eriksson, A., Lennartsson, A., & Lehmann, S. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.009 · Cited by 62
SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort
Tlemsani, C., Luscan, A., Leulliot, N., Bieth, É., Afenjar, A., Baujat, G., Doco‐Fenzy, M., Goldenberg, A., Lacombe, D., Lambert, L., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103638 · Cited by 57
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
Sato, H., Wheat, J. C., Steidl, U. G., & Ito, K. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00187 · Cited by 59
Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
Aberger, F., Hutterer, E., Sternberg, C., del Burgo, P. J., & Hartmann, T. N. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0163-4 · Cited by 56
Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia
Lal, R., LIND, K., Heitzer, E., Ulz, P., Aubell, K., Kashofer, K., Middeke, J. M., Thiede, C., Schulz, E., Rosenberger, A., et al. (2017) · Blood · doi:10.1182/blood-2016-11-751008 · Cited by 56
Rinaldi, L., Avgustinova, A., Martı́n, M., Datta, D., Solanas, G., Prats, N., & Benitah, S. A. (2017) · eLife · doi:10.7554/elife.21697 · Cited by 56
Therapeutic Targeting of the Premetastatic Stage in Human Lung-to-Brain Metastasis
Singh, M., Venugopal, C., Tokár, T., McFarlane, N., Subapanditha, M., Qazi, M. A., Bakhshinyan, D., Vora, P., Murty, N. K., Jurišica, I., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1022 · Cited by 56
Xie, T., Yu, J., Fu, W., Wang, Z., Xu, L., Chang, S., Wang, E., Zhu, F., Zeng, S., Kang, Y., et al. (2019) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp02024a · Cited by 55
Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
Dutta, S., Pregartner, G., Rücker, F. G., Heitzer, E., Zebisch, A., Bullinger, L., Berghold, A., Döhner, K., & Sill, H. (2020) · Cancers · doi:10.3390/cancers12030637 · Cited by 60
Grimwade, D. J., & Freeman, S. D. (2014) · Hematology · doi:10.1182/asheducation-2014.1.222 · Cited by 56
Nucleophosmin in Its Interaction with Ligands
Cela, I., Matteo, A. D., & Federici, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144885 · Cited by 56
Zhang, S., Huang, F., Wang, Y., Long, Y., Li, Y., Kang, Y., Gao, W., Zhang, X., Wen, Y., Wang, Y., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01548-y · Cited by 56
Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor–Initiating Cells
Venugopal, C., Hallett, R. M., Vora, P., Manoranjan, B., Mahendram, S., Qazi, M. A., McFarlane, N., Subapanditha, M., Nolte, S. M., Singh, M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3147 · Cited by 59
Rozhok, A. I., Salstrom, J. L., & DeGregori, J. V. (2014) · Aging · doi:10.18632/aging.100707 · Cited by 56
Mechanisms of DNA Methylation Regulatory Function and Crosstalk with Histone Lysine Methylation
Tibben, B. M., & Rothbart, S. B. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168394 · Cited by 61
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
Vyas, P., Appelbaum, F. R., & Craddock, C. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.10.026 · Cited by 54
Sinha, S., Thomas, D., Yu, L. C., Gentles, A. J., Jung, N., Corces, M. R., Chan, S. M., Reinisch, A., Feinberg, A. P., Dill, D. L., et al. (2014) · Blood · doi:10.1182/blood-2014-03-566018 · Cited by 60
Next Generation Sequencing of Acute Myeloid Leukemia: Influencing Prognosis
Ilyas, A. M., Ahmad, S., Faheem, M., Naseer, M. I., Kumosani, T., Al-Qahtani, M. H., Gari, M. A., & Ahmed, F. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s1-s5 · Cited by 55
Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis
Thol, F. R., Klesse, S., Köhler, L.-M., Gabdoulline, R. R., Kloos, A., Liebich, A., Wichmann, M., Chaturvedi, A., Fabisch, J., Gaidzik, V. I., et al. (2016) · Leukemia · doi:10.1038/leu.2016.345 · Cited by 52
Metadata
- Authors
- Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., McLeod, J. L., Doedens, M., Medeiros, J. J. F., Marke, R., Kim, H. J., Lee, K., McPherson, J. D., Hudson, T. J., Pan-Leukemia Gene Panel Consortium, T. H., Brown, A. M. K., Yousif, F., Trinh, Q. M., Stein, L. D., Minden, M. D., Wang, J. C. Y., & Dick, J. E.
- Affiliations
- University Health Network (CA)
- Chonnam National University (KR)
- Ontario Institute for Cancer Research (CA)
- Corresponding author
- Dick, John E.
- ORCID
- Venue
- Nature
- Published
- 2014-02-12
- Volume
- 506
- Issue
- 7488
- Pages
- 328-333
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4991939
- OpenAlex
- W2076031927
- Cited by
- 1,443
- References
- 53
- Citations by year
- 2026: 50 · 2025: 48 · 2024: 75 · 2023: 95 · 2022: 94 · 2021: 110 · 2020: 136 · 2019: 131 · 2018: 139 · 2017: 160 · 2016: 153 · 2015: 159 · 2014: 88
- FWCI
- 132.63
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-04-16)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Hospital for Sick Children
- Canadian Institutes of Health Research (105367_1)
- National Cancer Institute (R21CA152613)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- acute myeloid leukemia, DNMT3A mutation, NPM1 mutation, clonal evolution, treatment resistance, relapse, clonal expansion, chemotherapy remission, tumor heterogeneity, xenografts, mutation order, hematopoiesis
- MeSH terms
- DNA Methyltransferase 3A, Nucleophosmin, Animals, Cell Differentiation, Cell Division, Clone Cells, DNA (Cytosine-5-)-Methyltransferases, Female, Hematopoiesis, Hematopoietic Stem Cells, Humans, Isocitrate Dehydrogenase, Mutation, Neoplasm Transplantation, Nuclear Proteins, Remission Induction, T-Lymphocytes, Neoplastic Stem Cells, Leukemia, Myeloid, Acute, Mice, SCID, Mice, Inbred NOD, Drug Resistance, Neoplasm, Cell Lineage, Mice, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
